Medisinsk forskning på cannabis
I dette arkivet finner du over 15 000 lenker til forskningsartikler og studier på cannabis planten. Listen er på engelsk, delt opp i medisinske lidelser og andre kategorier i alfabetisk rekkefølge.
NB! Sidene på hver bokstav kan laste tregt da tusenvis av linker lastes
K-L
KIDNEYS (74)
-
Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy
-
Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy
-
Expression of cannabinoid receptors in human kidney
-
Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death
-
Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist
-
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
-
Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy
-
Is there a legitimate role for the therapeutic use of cannabinoids for symptom management in chronic kidney disease?
-
Distinctive effects of plant protein sources on renal disease progression and associated cardiac hypertrophy in experimental kidney disease
-
Cannabinoid hyperemesis syndrome inducing acute prerenal failure and electrolyte disturbance
-
β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner
-
AKI Associated with Synthetic Cannabinoids: A Case Series
-
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
-
Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats
-
Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice
-
Cannabinoid Receptor 2 Expression in Human Proximal Tubule Cells is Regulated by Albumin Independent of ERK1/2 Signaling
-
Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes
-
First Metabolic Profile of XLR-11, a Novel Synthetic Cannabinoid, Obtained by Using Human Hepatocytes and High-Resolution Mass Spectrometry
-
Acute Kidney Injury Associated with Synthetic Cannabinoid Use â Multiple States, 2012
-
Cannabinoid Receptors as Therapeutic Targets for Dialysis-Induced Peritoneal Fibrosis
-
Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy
-
Activation of G-protein-coupled receptor 40 attenuates the cisplatin-induced apoptosis of human renal proximal tubule epithelial cells
-
Nephrotoxic Effects of Common and Emerging Drugs of Abuse
-
Evaluation of the pharmacokinetics and safety of a single oral dose of fasiglifam in subjects with normal or varying degrees of impaired renal function
-
Nephrotoxic effects of designer drugs: synthetic is not better!
-
Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review
-
Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice
-
Acute kidney injury associated with smoking synthetic cannabinoid
-
Severe rhabdomyolysis and intracranial hemorrhage associated with synthetic cannabinoid: a case report
-
A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid
-
Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment
-
Elevated CB1 and GPR55 receptor expression in proximal tubule cells and whole kidney exposed to diabetic conditions
-
Targeting inflammation: new therapeutic approaches in chronic kidney disease (CKD)
-
Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases
-
Overexpression of g-protein-coupled receptor 40 enhances the mitogenic response to epoxyeicosatrienoic acids
-
Rhabdomyolysis and Acute Kidney Injury Requiring Dialysis as a Result of Concomitant Use of Atypical Neuroleptics and Synthetic Cannabinoids
-
Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists As Potential Treatment for Inflammatory Kidney Diseases
-
Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists As Potential Treatment for Inflammatory Kidney Diseases
-
Synthetic cannabinoids and acute kidney injury
-
A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure
-
Role of the Endocannabinoid System in Diabetes and Diabetic Complications
-
Renal effects of chronic pharmacological manipulation of CB2 receptors in rats with diet induced obesity
-
Chronic administration with AM251 improves albuminuria and renal tubular structure in obese rats
-
Chronic administration with AM251 improves albuminuria and renal tubular structure in obese rats
-
The endocannabinoid system in renal cell: Regulation of Na+ transport by CB1 receptors through distinct cell signaling pathways
-
The endocannabinoid system in renal cells: regulation of Na+ transport by CB1 receptors through distinct cell signalling pathways
-
Urinary early kidney injury molecules in children with beta-thalassemia major
-
Urinary early kidney injury molecules in children with beta-thalassemia major
-
The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases
-
High-throughput salting-out assisted liquid-liquid extraction with acetonitrile for the determination of anandamide in plasma of hemodialysis patients with liquid chromatography tandem mass spectrometry
-
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?
-
Synthetic Cannabinoids
-
Enhanced vasorelaxation effect of endogenous anandamide on thoracic aorta in renal vascular hypertension rats
-
Novel case of synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure
-
Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy
-
Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis
-
New insights into the yin and yang of the endocannabinoid system in health and disease
-
Uremic Pruritus Is Not Associated with Endocannabinoid Receptor 1 Gene Polymorphisms
-
Protective Action of Anandamide and its COX-2 Metabolite against L-Homocysteineinduced NLRP3 Inflammasome Activation and Injury in Podocytes
-
Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats
-
Cannabinoid Hyperemesis Syndrome Associated With Compulsive Showering and Acute Kidney Injury
-
Synthetic Cannabinoid Induced acute Tubulointerstitial Nephritis and Uveitis Syndrome: A Case Report and Review of Literature
-
AM251 Suppresses Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells
-
Dangerous drugs: products containing synthetic chemicals
-
Role of cannabinoid receptors in renal diseases
-
Toxicological impact of JWH-018 and its phase I metabolite N-(3-hydroxypentyl) on human cell lines
-
Anandamide and its metabolites: what are their roles in the kidney?
-
A multicenter retrospective survey of poisoning after consumption of products containing novel psychoactive substances from 2013 to 2014 in Japan
-
Association between plasma endocannabinoids and appetite in hemodialysis patients: A pilot study
-
Cannabinoid receptors in the kidney
-
Repeated Thrombosis After Synthetic Cannabinoid Use
-
Acute Effects of Synthetic Cannabinoids: Update 2015
-
Overactivation of cannabinoid receptor type 1 in rostral ventrolateral medulla promotes cardiovascular responses in spontaneously hypertensive rats
-
Thermolytic degradation of synthetic cannabinoids: chemical exposures and pharmacological consequences (link to
KNEE REPLACEMENT (1)
LEGIONNAIRES DISEASE (1)
LIVER DISEASE-NON HEPATITIS (128)
-
Effect of (-)-Delta(9)-tetrahydrocannabinoid on the hepatic redox state of mice
-
Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation
-
Recent advances in the understanding of the role of the endocannabinoid system in liver diseases
-
Role of the endocannabinoid system in alcoholic liver disease
-
Cannabinoid receptor type 1 expression modulates alcohol-induced liver fibrosis: Role of Acetaldehyde
-
Endogenous cannabinoids in liver disease: Many darts for a single target
-
Endocannabinoids in liver disease
-
Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver
-
Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis
-
Cannabidiol, a Major Phytocannabinoid, as a Potent Atypical Inhibitor for Cytochrome P450 2D6
-
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death
-
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
-
Central Endocannabinoid Signaling Regulates Hepatic Glucose Production and Systemic Lipolysis
-
Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration
-
Hepatic n-3 Polyunsaturated Fatty Acid Depletion Promotes Steatosis and Insulin Resistance in Mice: Genomic Analysis of Cellular Targets
-
Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice
-
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and cell death
-
Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance
-
Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating kupffer cell polarization in mice
-
A new cannabinoid 2 receptor agonist HU-910 attenuates oxidative stress, inflammation, and cell death associated with hepatic ischemia/reperfusion injury
-
Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats
-
Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes
-
The novel endocannabinoid virodhamine selectively induces cell death in hepatic stellate cells but not in hepatocytes
-
Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats
-
Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes
-
The novel endocannabinoid virodhamine selectively induces cell death in hepatic stellate cells but not in hepatocytes
-
Effect of cannabidiol treatment in alimentary induced fatty liver
-
Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle
-
Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic Fatty liver disease
-
Prevention of Fibrosis Progression in CCl4-Treated Rats: Role of the Hepatic Endo-cannabinoid and Apelin Systems
-
Î(8) -Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB(2) receptors
-
Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats
-
Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions
-
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharma-cological strategies and therapeutic possibilities
-
Characterization of In Vitro Metabolites of CP 47,497, a Synthetic Cannabinoid, in Human Liver Microsomes by LC-MS/MS
-
The endocannabinoid 2-arachidonoylglicerol decreases calcium induced cytochrome c release from liver mitochondria
-
Serum Metabolic Profiling Study of Hepatocellular Carcinoma Infected with Hepatitis B or Hepatitis C Virus by Using Liquid Chromatography-Mass Spectrometry
-
Influence of G1359A polimorphysm of the cannabinoid receptor gene (CNR1) on insulin resistance and adipokines in patients with non alcoholic fatty liver disease
-
Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver
-
Hepatic Cannabinoid Receptor Type 1 Mediates Alcohol-Induced Regulation of Bile Acid Enzyme Genes Expression Via CREBH
-
The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome
-
Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase
-
Cannabidiol is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19
-
Cannabinoid signaling and liver therapeutics
-
The role of endocannabinoids system in fatty liver disease and therapeutic potentials
-
US Patent Application 20130171145 â METHODS OF TREATING LIVER DISEASE
-
Effects of anandamide on proliferation of and pErk expression in primary hepatic stellate cells of schistosome-induced liver fibrosis mice
-
Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations
-
Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extra-cellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro
-
Functional relevance of the cannabinoid receptor 2 â heme oxygenase pathway: A novel target for the attenuation of portal hypertension
-
Protective effect of cannabidiol against cadmium hepatotoxicity in rats
-
The novel endocannabinoid noladin ether holds putative anti-fibrotic properties by selectively inducing cell death in hepatic stellate cells
-
A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids in inflammation-derived cardiovascular diseases
-
Endocannabinoid Receptors Gene Expression in Morbidly Obese Women with Nonalcoholic Fatty Liver Disease
-
Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides
-
Vascular targets for cannabinoids: animal and human studies
-
Cannabinoid receptor 1 gene polymorphisms and nonalcoholic Fatty liver disease in women with polycystic ovary syndrome and in healthy controls
-
Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy
-
Review article: the endocannabinoid system in liver disease, a potential therapeutic target
-
Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue
-
Inhibitory effect of synthetic cannabinoids on CYP1A activity in mouse liver micro-somes
-
The peripheral cannabinoid receptor 1 antagonist VD60 efficiently inhibits carbon tetrachloride-intoxicated hepatic fibrosis progression
-
CB1 blockade-induced weight loss over 48 weeks decreases liver fat in proportion to weight loss in humans
-
Upregulation of Cannabinoid Receptor-1 and Fibrotic Activation of Mouse Hepatic Stellate Cells during Schistosoma J. Infection: Role of NADPH Oxidase
-
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases
-
Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases: Focus on Î9-tetrahydrocannabinol pharmacology
-
Mechanism of endocannabinoids system in glucose metabolism of rats with chronic intermittent hypoxia
-
Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats
-
Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue
-
Activity of liver enzymes in multiple sclerosis patients with Hot-nature diet and cosupplemented hemp seed, evening primrose oils intervention
-
The antidiabetic and hepatoprotective effects of magnolol on diabetic rats induced by high-fat diet and streptozotocin
-
Protective Role of CB2 Receptor Activation in Galactosamine/LPS-induced Acute Liver Failure Through Regulation of Macrophage Polarization and miRNAs
-
Cannabidiol Rescues Acute Hepatic Toxicity and Seizure Induced by Cocaine
-
Ultra Low Dose Delta 9-Tetrahydrocannabinol Protects Mouse Liver from Ischemia Reperfusion Injury
-
Extraordinary cause of acute gastric dilatation and hepatic portal venous gas: Chronic use of synthetic cannabinoid
-
Bisdemethoxycurcumin Induces Apoptosis in Activated Hepatic Stellate Cells via Cannabinoid Receptor 2
-
Potent natural products and herbal medicines for treating liver fibrosis
-
α/β Hydrolase Domain-Containing 6 (ABHD6) Degrades the Late Endosomal / Lysosomal Lipid Bis(monoacylglycero)phosphate
-
Management of non-alcoholic fatty liver disease in 2015
-
Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells
-
Protective effect of Xingnaojia formulation on rats with brain and liver damage caused by chronic alcoholism
-
Orphan nuclear receptor oestrogen-related receptor γ (ERRγ) plays a key role in hepatic cannabinoid receptor type 1-mediated induction of CYP7A1 gene expression
-
Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoylglycerol and arachidonoyl-ethanolamide, and their metabolites
-
Intake of farmed Atlantic salmon fed soybean oil increases hepatic levels of arachidonic acid-derived oxylipins and ceramides in mice
-
Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury
-
CB1R antagonist increases hepatic insulin clearance in fat-fed dogs likely via upregulation of liver adiponectin receptors
-
Two non-psychoactive cannabinoids reduce intra-cellular lipid levels and inhibit hepatosteatosis
-
Anandamide Drives Cell Cycle Progression through CB1 Receptors in a Rat Model of Synchronized Liver Regeneration
-
Rimonabant inhibits proliferation, collagen secretion and induces apoptosis in hepatic stellate cells
-
Major urinary protein 1 interacts with cannabinoid receptor type 1 in fatty acid-induced hepatic insulin resistance in a mouse hepatocyte model
-
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?
-
Effects of dietary CLA on n-3 HUFA score and N-acylethanolamides biosynthesis in the liver of obese Zucker rats
-
CB1 receptor blockade counters age-induced insulin resistance and metabolic dysfunction
-
Vaccenic acid suppresses intestinal inflammation by increasing the endocannabinoid anandamide and non-cannabinoid signaling molecules in a rat model of the metabolic syndrome
-
The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage Autophagy-Dependent Pathway
-
Immunohistochemical analysis of cannabinoid receptor 1 expression in steatotic rat livers
-
The Orphan Nuclear Receptor ERRγ Regulates Hepatic CB1 Receptor-Mediated Fibroblast Growth Factor 21 Gene Expression
-
Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis
-
Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism
-
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring
-
Orexin-A represses satiety-inducing POMC neurons and contributes to obesity via stimulation of endocannabinoid signaling
-
Early Low Fat Diet Enriched with Linolenic Acid Reduces Liver Endocannabinoid Tone and Improves Late Glycemic Control After a High Fat Diet Challenge in Mice
-
Bisphenol A Induces Fatty Liver by an Endocannabinoid-Mediated Positive Feedback Loop
-
Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes
-
Long-Term Effects of Prenatal Exposure to Undernutrition on Cannabinoid Receptor Related Behaviors: Sex and Tissue-Specific Alterations in the mRNA Expression of Cannabinoid Receptors and Lipid Metabolic Regulators
-
In vitro metabolism of a novel synthetic cannabinoid, EAM-2201, in human liver microsomes and human recombinant cytochrome P450s
-
Curcumin and hemopressin treatment attenuates cholestasis-induced liver fibrosis in rats: role of CB1 receptors
-
Cyclooxygenase-2 contributes to the selective induction of cell death by the endocannabinoid 2-arachidonoyl glycerol in hepatic stellate cells
-
Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity
-
Cannabinoid receptors are involved in the protective effect of a novel curcumin derivative C66 against CCl4-induced liver fibrosis
-
Cannabinoid Receptor 1 Mediates Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury
-
Endocannabinoids signaling: Molecular mechanisms of liver regulation and diseases
-
Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats
-
Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias
-
Intake of a Western diet containing cod instead of pork alters fatty acid composition in tissue phospholipids and attenuates obesity and hepatic lipid accumulation in mice
-
Fabp-1 gene ablation impacts brain endocannabinoid system in male mice
-
β-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK signaling by activating CB2 receptor in human HepG2 hepatocytes
-
A multicenter retrospective survey of poisoning after consumption of products containing novel psychoactive substances from 2013 to 2014 in Japan
-
FABP1 in wonderland
-
Cannabinoids, inflammation, and fibrosis
-
Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels
-
FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein
-
Role of cannabis in digestive disorders
-
Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease
-
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia
-
Using proteomics to discover novel biomarkers for fatty liver development and response to CB1R antagonist treatment in an obese mouse model
-
Design, Synthesis and Biological Evaluation of Novel, Non-Brain Penetrant, Hybrid Cannabinoid CB1R Inverse Agonist/Inducible Nitric Oxide Synthase (iNOS) Inhibitors for the Treatment of Liver Fibrosis
-
Beta-caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice
LONG TERM USE EFFECTS (77)
-
Effects of cannabis on lung function: a population-based cohort study
-
Opioid antagonism enhances marijuanaâs effects in heavy marijuana smokers
-
Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use
-
An Evidence Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions
-
Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users
-
Increased Blood Pressure Following Abrupt Cessation of Daily Cannabis Use
-
Effects of Chronic Marijuana Use on Brain Activity During Monetary Decision-Making
-
Scientific Opinion on the safety of hemp (Cannabis genus) for use as animal feed
-
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation?
-
Characterizing smoking topography of cannabis in heavy users
-
Prolonged excretion half-life of 11-nor-9-carboxy-Îâ¹-THC following cessation in a chronic, heavy marijuana user: implications for liver transplant assessment.
-
Marijuana use among older adults in the U.S.A.: user characteristics, patterns of use, and implications for intervention
-
The histopathology of drugs of abuse
-
Psychomotor Performance, Subjective and Physiological Effects and Whole Blood Î9-Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following Acute Smoked Cannabis
-
Prevalences of illicit drug use in people aged 50 years and over from two surveys
-
Chronic Cannabis Abuse, Delta-9-tetrahydrocannabinol and Thyroid Function
-
Acute effects of THC on time perception in frequent and infrequent cannabis users
-
Functional connectivity in brain networks underlying cognitive control in chronic cannabis users
-
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)
-
Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO
-
A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid
-
Assessing topographical orientation skills in cannabis users
-
Cannabinoid hyperemesis syndrome: case report of a paradoxical reaction with heavy marijuana use
-
Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis
-
Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough?
-
Implicit Associations and Explicit Expectancies toward Cannabis in Heavy Cannabis Users and Controls
-
Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users
-
Impact of prolonged cannabinoid excretion in chronic daily cannabis smokersâ blood on per se drugged driving laws
-
Cannabis use: a perspective in relation to the proposed UK drug-driving legislation
-
Effects of marijuana smoking on the lung
-
Cannabis Cue Reactivity and Craving Among Never, Infrequent and Heavy Cannabis Users
-
Statistics on cannabis users skew perceptions of cannabis use
-
Marijuanaâs dose-dependent effects in daily marijuana smokers
-
Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers
-
Chronic cannabis abuse, delta-9-tetrahydrocannabinol and thyroid function
-
Creativity in cannabis-users and in drug addicts in maintenance treatment and in rehabilitation
-
Health outcomes associated with long-term regular cannabis and tobacco smoking
-
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis
-
Chronic Cannabis Abuse, Delta-9-tetrahydrocannabinol and Thyroid Function
-
THCCOOH concentrations in whole blood: Are they useful in discriminating occasional from heavy smokers?
-
Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium
-
Therapeutic benefits of cannabis: a patient surve
-
Couplesâ Marijuana Use Is Inversely Related to Their Intimate Partner Violence Over the First 9 Years of Marriage
-
Effects of Marijuana Exposure on Expiratory Airflow: A Study of Adults who Participated in the U.S. National Health and Nutrition Examination Study
-
High-Intensity Cannabis Use and Adherence to Antiretroviral Therapy Among People Who Use Illicit Drugs in a Canadian Setting
-
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters
-
Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice
-
Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls
-
Daily marijuana use is not associated with brain morphometric measures in adolescents or adults
-
Daily marijuana use is not associated with brain morphometric measures in adolescents or adults
-
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup
-
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men
-
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men
-
Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users
-
Effects of quitting cannabis on respiratory symptoms
-
Responsible and controlled use: Older cannabis users and harm reduction
-
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drugâs harm to children and adults, but the scientific evidence is seldom clear-cut
-
Differential effects of self-reported lifetime marijuana use on interleukin-1 alpha and tumor necrosis factor in African American adults
-
Residual cannabis levels in blood, urine and oral fluid following heavy cannabis use
-
Association Between Lifetime Marijuana Use and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
-
Minimal Physical Health Risk Associated With Long-term Cannabis UseâBut Buyer Beware
-
Associations Between Cannabis Use and Physical Health Problems in Early Midlife
-
Habituation of the startle reflex depends on attention in cannabis users
-
Association Between Regular Cannabis Use and Ganglion Cell Dysfunction
-
Retinal Ganglion Cell Dysfunction in Regular Cannabis Users Is the Evidence Strong Enough to Consider an Association?
-
MRI study of neural sensitization to hedonic stimuli in long-term, daily cannabis users
-
Grey Matter Changes Associated with Heavy Cannabis Use: A Longitudinal sMRI Study
-
Comparison of cannabinoids in hair with self-reported cannabis consumption in heavy, light and non-cannabis users
-
The effect of cannabis on regular cannabis consumersâ ability to ride a bicycle
-
Abrupt Quitting of Long-term Heavy Recreational Cannabis Use is Not Followed by Significant Changes in Blood Pressure and Heart Rate
-
Cannabinoids: Medical implications
-
Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample
-
Are We Using the Right Model of Cannabis Tolerance?
-
The effects of cannabis use on salience attribution: a systematic review
-
Alcohol and cannabis: Comparing their adverse health effects and regulatory regimes
-
Peer Network Counseling as Brief Treatment for Urban Adolescent Heavy Cannabis Users
-
Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and cued-arousal among veterans who screen positive for PTSD
LUNG FUNCTION (75)
-
Does cannabis use predispose to chronic airflow obstruction?
-
âBong lungâ in cystic fibrosis: a case report
-
Targeting the cannabinoid pathway limits the development of fibrosis and auto-immunity in a mouse model of systemic sclerosis
-
Effects of cannabis on lung function: a population-based cohort study
-
DOSE-DEPENDENT EFFECTS ON VENTILATION AT REST INDUCED BY HIGH DOSES OF CANNABINOIDS IN RATS
-
Cannabinoid effects on ventilation and breathlessness: A pilot study of efficacy and safety (link to
-
Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation
-
The histopathology of drugs of abuse
-
Association Between Marijuana Exposure and Pulmonary Function Over 20 Years
-
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A(2A) receptor
-
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice
-
Honokiol attenuates the severity of acute pancreatitis and associated lung injury via acceleration of acinar cell apoptosis
-
Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice
-
High Times, Low Sats: Diffuse Pulmonary Infiltrates Associated with Chronic Synthetic Cannabinoid Use
-
Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction
-
Effects of marijuana smoking on the lung
-
Cannabis and the Lung: No More Smoking Gun?
-
The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig
-
Protective effect of magnolol on lipopolysaccharide-induced acute lung injury in mice
-
Health outcomes associated with long-term regular cannabis and tobacco smoking
-
Synthetic Marijuana: Possibly A Lungâs Dying Breath
-
Synthetic Cannabinoids as a Cause for Black Carbonaceous Bronchoalveolar Lavage
-
Diffuse Hemorrhagic Pulmonary Infiltrates: Unique Complication Of Synthetic Cannabinoid Abuse
-
The Synthetic Cannabinoid Ajulemic Acid Exerts Anti-Fibrotic Effects In Bleomycin Induced Pulmonary Fibrosis
-
CB2 Receptor Activation Ameliorates the Proinflammatory Activity in Acute Lung Injury Induced by Paraquat
-
Cardiorespiratory Anomalies in Mice Lacking CB1 Cannabinoid Receptors
-
Effect of melilotus extract on lung injury by upregulating the expression of cannabinoid CB2 receptors in septic rats
-
Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors
-
Effects of Marijuana Exposure on Expiratory Airflow: A Study of Adults who Participated in the U.S. National Health and Nutrition Examination Study
-
Pulmonary Effects of Synthetic Marijuana: Chest Radiography and CT Findings
-
Does cannabis smoking predispose to lung bulla formation?
-
Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury
-
The Endocannabinoid Anandamide Mediates Hypoxic Pulmonary Vasoconstriction And Pulmonary Hypertension
-
Acute Lung Injury Due To Synthetic Cannabis
-
Cannabis, tobacco smoking, and lung function: a cross-sectional observational study in a general practice population
-
Synthetic cannabinoids as a cause for black carbonaceous bronchoalveolar lavage
-
Unintentional Pediatric Exposure to a Synthetic Cannabinoid (AB-PINACA) Resulting in Coma and Intubation
-
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup
-
The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity
-
No smoke, no fire: What the initial literature suggests regarding vapourized cannabis and respiratory risk
-
Î9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells
-
The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough
-
Effects of quitting cannabis on respiratory symptoms
-
Endogenous 2-Arachidonoylglycerol Alleviates Cyclooxygenases-2 Elevation-Mediated Neuronal Injury from SO2 Inhalation via PPARγ Pathway
-
Protection from Radiation-Induced Pulmonary Fibrosis by Peripheral Targeting of Cannabinoid Receptor-1
-
How beneficial is vaping cannabis to respiratory health compared to smoking?
-
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drugâs harm to children and adults, but the scientific evidence is seldom clear-cut
-
A New Threat: Synthetic Marijuana Associated Lung Disease
-
Dabble With Danger: A Case Of Severe Respiratory Failure Following Inhalation Of Butane Hash Oil
-
Acute Eosinophilic Pneumonia With Respiratory Failure Induced By âBonzaiâ (Synthetic Cannabinoid) Inhalation
-
Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats
-
Peripheral Targeting of CB1 Cannabinoid Receptors Protects from Radiation-Induced Pulmonary Fibrosis
-
Protection from Radiation-Induced Pulmonary Fibrosis by Peripheral Targeting of Cannabinoid Receptor-1
-
Genotoxic properties of XLR-11, a widely consumed synthetic cannabinoid, and of the benzoyl indole RCS-4
-
A Randomized Placebo Controlled Trial of Ibuprofen for Respiratory Syncytial Virus Infection in a Bovine Model
-
Legal regulated markets have the potential to reduce population levels of harm associated with cannabis use
-
Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center
-
Medical cannabis use in Canada: vapourization and modes of delivery
-
Acute Eosinophilic Pneumonia with Respiratory Failure Induced by Synthetic Cannabinoid Inhalation
-
Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy.
-
Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats
-
The Endogenous Cannabinoid Anandamide Increases Human Airway Epithelial Cell Permeability through an Arachidonic Acid Metabolite
-
Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen induced pulmonary inflammation in mice
-
Stimulation of cannabinoid CB1 receptors prevents nerve-mediated airway hyperreactivity in NGF-induced inflammation in mouse airways
-
Cannabinoids: Medical implications
-
Cannabis â Position Paper of the German Respiratory Society (DGP)
-
Activation of cannabinoid CB1 receptors suppresses the ROS-induced hypersensitivity of rat vagal lung C-fiber afferents
-
The cannabinoid 2 receptor agonist β-caryophyllene modulates the inflammatory reaction induced by Mycobacterium bovis BCG by inhibiting neutrophil migration
-
Alveolar haemorrhage following a cannabis water pipe
-
Acute effects of cannabis on breath-holding duration
-
Repeated Thrombosis After Synthetic Cannabinoid Use
-
Î9-Tetrahydrocannabinol Reverses TNFα-induced Increase in Airway Epithelial Cell Permeability through CB2 Receptors
-
Targeting brain and peripheral plasticity of the lipidome in acute kainic acid-induced epileptic seizures in mice via quantitative mass spectrometry
-
The consequences of chronic cannabis smoking in vulnerable adolescents
-
Influence of history of cannabis smoking in selected donors on the outcomes of lung transplantation
